Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Custodian Property launches £5m share buyback

(Sharecast News) - Custodian Property Income REIT announced the launch of a share buyback programme of up to £5m on Thursday, citing what it sees as a material undervaluation of the company and its portfolio in the current market. The London-listed firm said the buyback, to be conducted by Deutsche Numis on behalf of the company, was following a series of selective disposals that had raised £41.8m since April 2023.

It noted that the assets were sold at an average premium of 8% to book value, with a focus on properties seen as having limited rental growth potential.

Further disposals exceeding £5m were planned for the rest of the financial year.

Proceeds from asset sales had so far been used to reduce variable rate debt and fund capital expenditure to enhance the environmental credentials of the portfolio.

The company said it had lowered its loan-to-value ratio from 27.4% in March 2023 to 25.6% as of March 2025, adjusted for post-period sales.

Its board said the current share price failed to reflect the quality and security of the company's fully covered dividend, and that the buyback was expected to enhance earnings per share and net asset value per share for remaining shareholders.

The buyback would be conducted under the authority granted at the August 2024 annual general meeting, and may cover up to 10% of the company's issued share capital.

Shares repurchased would be held in treasury.

The board said it would keep the programme under review and could cancel or amend it at any time.

At 1322 BST, shares in Custodian Property REIT were down 0.44% at 81.54p.

Reporting by Josh White for Sharecast.com.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.